Suppr超能文献

透析治疗的泌尿系统疾病患儿,其血红蛋白和白蛋白目标达标率无差异。

No difference in meeting hemoglobin and albumin targets for dialyzed children with urologic disorders.

机构信息

Division of Pediatric Nephrology, Johns Hopkins University, 200 N. Wolfe St., Baltimore, MD 21287, USA.

出版信息

Pediatr Nephrol. 2011 Jul;26(7):1129-36. doi: 10.1007/s00467-011-1850-9. Epub 2011 Mar 20.

Abstract

Urologic disorders are the most common cause of chronic kidney disease in children. To determine whether children with urologic etiology of end-stage renal disease (ESRD) fare better than children with ESRD from other causes while on dialysis, we conducted a cross-sectional study of children <18 years receiving peritoneal and hemodialysis in the United States using data from the Centers for Medicare & Medicaid Services 2005 ESRD CPM Project. We compared baseline demographics and the study groups. In multivariate logistic regression analysis of 1,286 subjects, we assessed whether children with urologic disorders had a higher odds of meeting adult KDOQI targets for hemoglobin levels ≥11 g/dl and albumin ≥3.5 BCG/3.2 BCP g/dl. We conducted a subset analysis of 1,136 patients to examine the impact of erythropoietin on hemoglobin targets. Our results did not reveal differences in achievement of adult hemoglobin targets (adjusted OR: 1.27; p value 0.09; CI: 0.97-1.66) or in the subset analysis with erythropoietin (adjusted OR: 1.32; p value 0.06; CI: 0.98-1.78) or albumin targets (adjusted OR: 1.22; p value 0.21; CI: 0.90-1.65) in adjusted analyses. Due to our study's limitations, it is difficult to determine whether this may result from treatment prior to dialysis initiation or treatment effect of dialysis rather than underlying diagnosis.

摘要

泌尿科疾病是儿童慢性肾脏病的最常见病因。为了确定患有终末期肾病(ESRD)的泌尿科病因的儿童在接受透析治疗时是否比患有其他病因的 ESRD 儿童的预后更好,我们利用医疗保险和医疗补助服务中心(Centers for Medicare & Medicaid Services)2005 年 ESRD CPM 项目的数据,对美国接受腹膜和血液透析治疗的<18 岁儿童进行了一项横断面研究。我们比较了两组的基线人口统计学特征和研究组。在对 1286 名受试者进行的多变量逻辑回归分析中,我们评估了患有泌尿科疾病的儿童是否具有更高的机会满足成人 KDOQI 目标,即血红蛋白水平≥11 g/dl 和白蛋白≥3.5 BCG/3.2 BCP g/dl。我们对 1136 名患者进行了亚组分析,以检查促红细胞生成素对血红蛋白目标的影响。我们的结果并未显示在达到成人血红蛋白目标方面存在差异(调整后的 OR:1.27;p 值 0.09;95%CI:0.97-1.66),也未显示在使用促红细胞生成素的亚组分析中存在差异(调整后的 OR:1.32;p 值 0.06;95%CI:0.98-1.78)或白蛋白目标(调整后的 OR:1.22;p 值 0.21;95%CI:0.90-1.65)在调整后的分析中。由于我们研究的局限性,很难确定这是否是由于透析前治疗或透析的治疗效果而不是潜在诊断导致的。

相似文献

1
No difference in meeting hemoglobin and albumin targets for dialyzed children with urologic disorders.
Pediatr Nephrol. 2011 Jul;26(7):1129-36. doi: 10.1007/s00467-011-1850-9. Epub 2011 Mar 20.
4
Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease.
Clin J Am Soc Nephrol. 2013 Nov;8(11):1927-34. doi: 10.2215/CJN.04310413. Epub 2013 Aug 22.
5
Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year.
Clin J Am Soc Nephrol. 2010 Sep;5(9):1574-81. doi: 10.2215/CJN.01320210. Epub 2010 Jun 10.
6
Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis.
Kidney Int. 2017 Jan;91(1):177-182. doi: 10.1016/j.kint.2016.09.013. Epub 2016 Nov 16.
7
Adolescent hemodialysis: results of the 2000 ESRD Clinical Performance Measures Project.
Pediatr Nephrol. 2002 Jan;17(1):10-5. doi: 10.1007/s004670200002.
8
Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.
Pediatr Nephrol. 2018 Aug;33(8):1411-1417. doi: 10.1007/s00467-018-3948-9. Epub 2018 Apr 4.
9
Parenteral iron use: possible contribution to exceeding target hemoglobin in hemodialysis patients.
Clin J Am Soc Nephrol. 2009 Mar;4(3):623-9. doi: 10.2215/CJN.03850808. Epub 2009 Feb 11.
10
Hospitalization rates and clinical performance measures in U.S. adolescent hemodialysis patients.
Pediatr Nephrol. 2010 Nov;25(11):2335-41. doi: 10.1007/s00467-010-1597-8. Epub 2010 Jul 29.

本文引用的文献

1
Strict blood-pressure control and progression of renal failure in children.
N Engl J Med. 2009 Oct 22;361(17):1639-50. doi: 10.1056/NEJMoa0902066.
2
What do we know about chronic renal failure in young adults? II. Adult outcome of pediatric renal disease.
Pediatr Nephrol. 2009 Oct;24(10):1921-8. doi: 10.1007/s00467-008-1107-4. Epub 2009 Feb 4.
3
Survival advantage of pediatric recipients of a first kidney transplant among children awaiting kidney transplantation.
Am J Transplant. 2008 Dec;8(12):2600-6. doi: 10.1111/j.1600-6143.2008.02410.x. Epub 2008 Sep 18.
4
Analyses of age, gender and other risk factors of erythropoietin resistance in pediatric and adult dialysis cohorts.
Pediatr Nephrol. 2009 Mar;24(3):571-9. doi: 10.1007/s00467-008-0954-3. Epub 2008 Sep 18.
5
Erythropoietin dosing in children with chronic kidney disease: based on body size or on hemoglobin deficit?
Pediatr Nephrol. 2009 Mar;24(3):435-7. doi: 10.1007/s00467-008-0955-2. Epub 2008 Aug 12.
6
Clinical outcome of children with chronic kidney disease in a pre-dialysis interdisciplinary program.
Pediatr Nephrol. 2008 Nov;23(11):2039-46. doi: 10.1007/s00467-008-0868-0. Epub 2008 Jun 17.
7
Serum albumin level and risk for mortality and hospitalization in adolescents on hemodialysis.
Clin J Am Soc Nephrol. 2008 May;3(3):759-67. doi: 10.2215/CJN.02720707. Epub 2008 Feb 20.
10
Chronic kidney disease in children: the global perspective.
Pediatr Nephrol. 2007 Dec;22(12):1999-2009. doi: 10.1007/s00467-006-0410-1. Epub 2007 Feb 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验